FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Meehan Steven
2. Issuer Name and Ticker or Trading Symbol

Kadmon Holdings, Inc. [ KDMN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Chief Financial Officer
(Last)          (First)          (Middle)

C/O KADMON HOLDINGS, INC., 450 E. 29TH STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

11/9/2021
(Street)

NEW YORK, NY 10016
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/9/2021  D  24909 D$9.50 (1)0 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) $4.12 11/9/2021  D     25000   (2)6/29/2027 Common Stock, par value $0.001 25000 $5.38 (3)0 D  
Stock Option (right to buy) $3.35 11/9/2021  D     25000   (2)7/27/2028 Common Stock, par value $0.001 25000 $6.15 (3)0 D  
Stock Option (right to buy) $2.17 11/9/2021  D     400000   (2)2/8/2029 Common Stock, par value $0.001 400000 $7.33 (3)0 D  
Stock Option (right to buy) $4.34 11/9/2021  D     500000   (2)1/27/2030 Common Stock, par value $0.001 500000 $5.16 (3)0 D  
Stock Option (right to buy) $3.96 11/9/2021  D     1020000   (2)1/8/2031 Common Stock, par value $0.001 1020000 $5.54 (3)0 D  

Explanation of Responses:
(1) Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
(2) In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option
(3) Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Meehan Steven
C/O KADMON HOLDINGS, INC.
450 E. 29TH STREET
NEW YORK, NY 10016


EVP, Chief Financial Officer

Signatures
/s/ Gregory S. Moss, Attorney-in-Fact11/9/2021
**Signature of Reporting PersonDate

Kadmon (NASDAQ:KDMN)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Kadmon Charts.
Kadmon (NASDAQ:KDMN)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Kadmon Charts.